New lens aims to correct both cataracts and astigmatism in one go

NCT ID NCT06285695

First seen Jun 26, 2026 · Last updated Jul 29, 2026 · Updated 2 times

Summary

This study is checking the long-term safety and performance of a special lens called the Clareon Toric IOL, which is implanted during cataract surgery to also correct astigmatism. About 129 people with cataracts and astigmatism are taking part. The main goal is to see how well the lens improves vision and how stable it stays in the eye over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Clareon Toric intraocular lens (IOL)
What this could lead to
If successful, this could confirm that Clareon Toric IOLs are a safe and effective long-term option for correcting both cataracts and astigmatism in one surgery.
What could go wrong
This is a post-market study, so the device is already approved. The main risk is that long-term results may show unexpected issues like lens rotation or residual astigmatism, but serious problems are unlikely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHAKIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bellevue

    Montreal, Quebec, H1V 1G5, Canada

  • Gimbel Eye Centre

    Calgary, Alberta, T3B 0M3, Canada

  • Laurentians Eye Institute

    Boisbriand, Quebec, J7H 0E8, Canada

  • McGill University

    Montreal, Quebec, R7A 3N2, Canada

  • Prism Eye Institute

    Oakville, Ontario, L6H 0J8, Canada

  • Uptown Eye Specialists

    Concord, Ontario, L4K 2Z5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.